CD40LG and scleroderma: In this regard, platelets are the main source of these molecules in the circulation [38–40], and the authors of previous reports have described increased levels of serum CD40L in scleroderma patients [41] and increased serum TGF-β in patients with Raynaud’s phenomenon [10].